Robert Lenkinski, PhD

Robert Lenkinski is a chemist by training. He received his PhD in Chemistry in 1973 from the University of Houston. Dr. Lenkinski was a post-doctoral fellow at the Weizmann Institute from 1973-1975. In 1986, he was recruited to the Department of Radiology at the University of Pennsylvania, where he was involved in the technical development of MRI and MRS and their translation to clinical studies. One of his first contributions was as one of the four co-inventors of the endorectal coil for prostate MRI. In the early 1990’s, Dr. Lenkinski became involved in MR imaging of breast cancer in patients. His group designed and constructed a biopsy capable Multicoil array for MR imaging and localized MR spectroscopy (MRS). Dr. Lenkinski participated in a number of successful MRI based clinical trials in both prostate and breast cancer. 1999, he was recruited to the Department of Radiology of the Beth Israel Deaconess Medical Center, one of the major teaching hospitals of Harvard Medical School, where he continued to pursue the technical development of both MRI and MRS on the first 3T Whole Body MRI system with a body coil. Dr. Lenkinski was recruited as a Professor and Vice Chair of Research in the Department of Radiology at the UT Southwestern Medical Center in Dallas in 2011 with a multimillion Grant Award, the first Missing Link award from the Cancer Prevention and Research Institute of Texas (CPRIT). In addition to continuing his research efforts in the technical development of MRI, Dr. Lenkinski created a successful research program in Spectral CT. He retired from this position in 2019 and moved to Tel Aviv Israel. He is currently an Adjunct Professor in the Department of Radiology at UT Southwestern Medical Center.

An up-to-date copy of Dr. Lenkinski’s CV can be found on his web site

(https://robertlenkinski.academia.edu).